FDA Inspection 876725 — Henry A Frazer, Pharm D, Clinical Investigator
The FDA completed an inspection of Henry A Frazer, Pharm D, Clinical Investigator on April 3, 2014 in Montgomery, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 3, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Montgomery, AL (United States)
Additional Details
Clinical Investigator (CI)